Biotech Values

[stockbettor]

MNTA’s Valuation in the Single-Generic Lovenox Scenarios

Does the fact that sanofi announced it generics sub will produce a Plavix authorized generic (and will sell other generics "when appropriate") change your assessment of MNTA's potential value?

http://www.reuters.com/article/rbssHealthcareNews/idUSL564810320091005

Sanofi to start selling own generic Plavix-report

PARIS, Oct 5 (Reuters) - Sanofi-Aventis (SASY.PA) will start selling its own generic version of its blood-clot treatment Plavix this week through its Winthrop unit, La Lettre de L'Expansion reports on Monday.

The move is aimed at beating other generic drug makers, which are planning to sell their own versions this autumn, the French newsletter said.

La Lettre de L'Expansion did not specify on which markets Sanofi planned to launch the generic version of Plavix.

A Sanofi spokesman said the group's strategy was to sell its own version of generic drugs when appropriate but he had no immediate comment on the timing of a Plavix launch. (Reporting by Dominique Vidalon, Ben Hirschler; Editing by Hans Peters)

For an amusinig translation of the original article, see

http://translate.google.com/translate?hl=en&sl=fr&tl=en&u=http%3A%2F%2Fwww.moneyweek.fr%2Fconseils%2F01766%2Fsanofi-aventis-creation-generique-plavix-contre-concurrence.html